Biotrol Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.20 M
as on 11-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.79 Cr
as on 11-12-2024
- Satisfied Charges ₹ 8.80 M
as on 11-12-2024
- Revenue 1.00%
(FY 2022)
- Profit 37.60%
(FY 2022)
- Ebitda -0.29%
(FY 2022)
- Net Worth 22.31%
(FY 2022)
- Total Assets 3.32%
(FY 2022)
About Biotrol Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹3.79 Cr. The company has closed loans amounting to ₹8.80 M, as per Ministry of Corporate Affairs (MCA) records.
Virender Suri and Mohan Suri serve as directors at the Company.
- CIN/LLPIN
U24232DL2011PTC214260
- Company No.
214260
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biotrol Laboratories Private Limited offer?
Biotrol Laboratories Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Sexual Wellness Products, Female Hygiene Products & Test Kits.
Who are the key members and board of directors at Biotrol Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virender Suri  | Director | 09-Mar-2015 | Current |
| Mohan Suri | Director | 09-Mar-2015 | Current |
Financial Performance of Biotrol Laboratories.
Biotrol Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1% increase. The company also saw a substantial improvement in profitability, with a 37.6% increase in profit. The company's net worth Soared by an impressive increase of 22.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotrol Laboratories?
In 2022, Biotrol Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jan 2024 | ₹5.00 M | Open |
Others Creation Date: 18 Dec 2020 | ₹7.86 M | Open |
Others Creation Date: 18 Dec 2020 | ₹2.50 Cr | Open |
How Many Employees Work at Biotrol Laboratories?
Unlock and access historical data on people associated with Biotrol Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotrol Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotrol Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
